Key result
Immune cell activation and cytokine release directly drive hypertension-induced target organ damage.
Why the study?
Hypertension is associated with functional-structural alterations of target organs, motivating an evaluation of recent correlations between the immune system, hypertension, and target-organ damage.
Does immune system activation contribute to target organ damage in hypertensive conditions?
Systematic Review
Does immune system activation contribute to target organ damage in hypertensive conditions?
Highlights the critical role of immune cells and inflammation in the pathophysiology of hypertension-mediated organ damage, suggesting potential novel therapeutic targets.
Supports testing immunomodulatory therapies in hypertension; confirms T-cell and cytokine pathways as drivers of organ damage.
BACKGROUND: Hypertension is a chronic, multifactorial clinical condition characterized by sustained high blood pressure levels. It is often associated with functional-structural alterations of target organs, which include heart, brain, kidneys, and vasculature. OBJECTIVE: This study highlights the recent correlation between the immune system and hypertension and its repercussions on target-organ damage. METHODS: The descriptors used for the search of the study were "hypertension", "immunity", and "target organs". The methodology of the study followed the main recommendations of the PRISMA statement. RESULTS: The damage to the vasculature arises mainly from the migration of T cells and monocytes that become pro-inflammatory in the adventitia, releasing TNF-α, IFN-γ, and IL-17, which induce endothelial damage and hinder vascular relaxation. In the renal context, the inflammatory process associated with hypertension culminates in renal invasion by leukocytes, which contribute to the injury of this organ by mechanisms of intense sympathetic stimulation, activation of the reninangiotensin system, sodium retention, and aggravation of oxidative stress. In the cardiac context, hypertension increases the expression of pro-inflammatory elements, such as B, T, and NK cells, in addition to the secretion of IFN-γ, IL-17, IL-23, and TNF-α from angiotensin II, reactive oxygen species, and aldosterone. This pro-inflammatory action is also involved in brain damage through SphK1. In view of the above, the participation of the immune system in hypertension-induced injuries seems to be unequivocal. CONCLUSION: Therefore, understanding the multifactorial mechanisms related to hypertension will certainly allow for more efficient interventions in this condition, preventing target organ damage.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2022) conducted a systematic review in Systemic arterial hypertension and target organ damage. Immune system activation and inflammation was evaluated on Target organ damage (vasculature, kidneys, heart, and brain). The immune system unequivocally participates in hypertension-induced target organ damage through the migration of T cells and monocytes and the release of pro-inflammatory cytokines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: